Growth stocks aren’t supposed to be cheap. Investors willingly pay higher multiples for companies that are expected to grow earnings over the next few years. With the stock market trading at all-time highs, even that premium is becoming difficult to justify for many growth investors. Times like these force them to look for growth opportunities that are available at attractive valuations.
Angelo Kourkafas, a CFA and Senior Global Investment Strategist at financial services firm Edward Jones, pointed out the importance of attractive valuation in today’s geopolitically charged environment. In his weekly market wrap on the company’s blog, he stated:
Market leadership is likely to broaden, volatility may normalize from low levels, and returns could become less momentum-driven and more dependent on earnings delivery, valuation discipline and sector rotation.
If investors can find stocks trading at low valuations, it will not only help maximize future returns but also protect against the de-rating risk resulting from potentially higher borrowing costs. In our quest to find such undervalued opportunities in the market, we decided to create a list of the most undervalued growth stocks to buy for the next 10 years.
Our Methodology
To compile our list of the top 8 most undervalued growth stocks to buy for the next 10 years, we considered only companies with a market cap of at least $2 billion. We then shortlisted stocks trading at a forward PE multiple of less than 15x and with expected earnings growth of more than 30% over the next 5 years. These stocks have reported recent investor-worthy news and are ranked from the highest to the lowest forward PE multiple.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
Note: All share price data is as of July 10, 2026.
8. The Chemours Company (NYSE:CC)
Forward P/E: 12.55
According to a report released on July 6, BMO Capital analyst John McNulty reiterated a Buy rating on The Chemours Company (NYSE:CC) with a price target of $26. The firm’s assigned price target is close to the median Wall Street analysts’ price target of $25, according to 11 analysts covering the stock. Moreover, the stock is currently trading about 11% below the lowest Wall Street price target of $21.
In contrast to BMO Capital, Mizuho Securities cut its price target on The Chemours Company (NYSE:CC) from $30 to $25 while keeping its Outperform rating on July 1. The firm’s downward-adjusted price target still presents a further 32% upside from current levels. Mizuho Securities updated its outlook for the chemical sector as part of its second-quarter earnings preview. The firm lowered price targets for most basic chemical companies.
According to Mizuho Securities, the recent decline in oil prices has reduced the expected cost advantage of natural gas for many basic chemical producers. At the same time, the firm believes that continued investment in advanced computing infrastructure will support demand for technology materials over the longer term.
The Chemours Company (NYSE:CC) is a global specialty chemicals company. The company operates in the Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials segments. It is based in Wilmington, Delaware, and serves customers worldwide.
7. Phillips 66 (NYSE:PSX)
Forward P/E: 12.15
Phillips 66 (NYSE:PSX) is one of the most undervalued growth stocks to buy for the next 10 years. On July 2, Wells Fargo analyst Sam Margolin maintained a Buy rating on the stock. The analyst also assigned a target price of $201 to the stock.
Earlier, on June 24, CEO Mark Lashier said that refining and petrochemical companies will continue to see greater volatility due to uncertainty stemming from disruptions in the Strait of Hormuz. He added that the company reduced its refining costs by about $1 per barrel and aims to lower costs further to $5.50 per barrel. However, refining operations in California remain more expensive, with costs around $15 per barrel. Moreover, the company has improved its refinery performance by producing higher-value products. Lashier remarked:
We actually have improved our yield of high-value products for our refineries, and we’ve enhanced our utilization, running our refineries at higher rates as we’ve lowered the cost
Additionally, it will take time for global crude oil supplies to return to normal because uncertainty remains around shipping through the Strait of Hormuz. Around 90 to 100 million barrels of crude oil are still stuck in the region. This is because there isn’t enough room to store more oil. As a result, it will take a long time for the supply bottleneck to clear.
CEO Mark Lashier, highlighting the challenges of restoring normal oil flows, said:
We believe that most of the tanks on shore are full before crude can appreciably ramp up. You have to get some room in those tanks to place that crude, and so it’s going to be a long, drawn-out process
Phillips 66 (NYSE:PSX) operates as an integrated downstream energy provider across the United States, the United Kingdom, Germany, and international markets. The company is headquartered in Houston, Texas.
6. Dana Inc. (NYSE:DAN)
Forward P/E: 11.17
On July 7, Deutsche Bank lowered its price target on Dana Inc. (NYSE:DAN) to $39 from $40 and maintained a Buy rating on the stock. Based on the revised price target, there is a 53% upside from current levels. This upside is lower than the median Wall Street analysts’ upside of 61% based on 10 analysts’ estimates.
In our previous coverage of the stock, we mentioned the company’s acquisition of Eaton’s Mobility Group. This acquisition was believed to enhance Dana’s long-term business profile through higher margins, increased aftermarket exposure, and greater scale. On June 10, both companies entered into definitive agreements for a Reverse Morris Trust transaction. As part of the transaction, Eaton will transfer its Vehicle and eMobility business into the newly created SpinCo before it merges with Dana. A Separation and Distribution Agreement will govern this transfer. Additionally, a Dana subsidiary will also acquire Royal Precision Holding Corp. from Eaton, adding further assets to the combined company.
Dana and SpinCo secured a $2.6 billion short-term bridge loan commitment from Goldman Sachs to help fund the transaction. The financing will be used to support an approximately $1.1 billion cash payment to Eaton and to refinance certain existing Dana debt. However, the transaction is still subject to several conditions, including DAN shareholder approval and multiple regulatory clearances.
Dana Inc. (NYSE:DAN), together with its subsidiaries, provides power-conveyance and energy-management solutions for on-highway vehicles. The company also provides sealing solutions such as gaskets, seals, cam covers, and oil pan modules. It was founded in 1904 and is headquartered in Maumee, Ohio.
5. Halozyme Therapeutics Inc. (NASDAQ:HALO)
Forward P/E: 11.12
On June 16, H.C. Wainwright analyst Mitchell Kapoor reiterated a Buy rating on Halozyme Therapeutics Inc. (NASDAQ:HALO) and assigned a target price of $95. The stock’s potential has been noticed by market participants, as evident from the 46% rise in the last 12 months. With earnings growth expected to continue, HALO is one of our most undervalued growth stocks to buy for the next 10 years.
On a more positive front, on June 13, Johnson & Johnson announced that Halozyme-partnered Darzalex Faspro, when used with its cancer drug Talvey, significantly improved survival outcomes in a late-stage trial for patients with multiple myeloma. The combination reduced the risk of death by up to 53% compared with the standard treatment. Darzalex Faspro is a front-line multiple myeloma therapy. The combination of two drugs, after about two years of follow-up, reduced the risk of cancer worsening or death by up to 72%. Additionally, at 24 months, about 89% of patients were alive, compared with 79% of those receiving standard care. The positive trial results could benefit HALO by supporting continued adoption of Darzalex Faspro, which uses the company’s ENHANZE technology.
Halozyme Therapeutics Inc. (NASDAQ:HALO) is a biopharmaceutical company. It researches, develops, and commercializes proprietary enzymes and devices. The company’s products are based on the patented recombinant human hyaluronidase enzyme that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules. The company was founded in 1998 and is headquartered in San Diego, California.
4. Happen Inc. (NASDAQ:HAPN)
Forward P/E: 11.07
On June 30, BTIG raised the firm’s price target on Happen Inc. (NASDAQ:HAPN) to $25 from $20 and kept a Buy rating on the stock. The upward price target revision reflects a 28% upside from current levels. This upside is higher than the median Wall Street analysts’ upside of 18% based on 10 analysts’ estimates. The firm updated its forecasts for specialty finance companies ahead of the second-quarter earnings season. It believes the revised price targets reflect where the stock could trade by June 2027. Moreover, many companies in the sector will see significant earnings improvement as inflation concerns ease and the outlook for Federal Reserve interest rates becomes clearer, BTIG tells investors in a research note.
Earlier on June 22, Happen Inc. announced the official launch of the Happen Bank brand. Also, on the same day, the company was listed on Nasdaq. Moreover, HAPN represents the company’s goal of helping customers achieve their financial goals by offering products that are simple, clear, and easy to use.
Scott Sanborn, CEO of Happen Bank, remarked:
Becoming Happen Bank and now trading on Nasdaq reflects how far we’ve come in building a modern digital bank designed around people’s real financial needs. The Happen Bank brand more clearly reflects the role we play in consumers’ lives: helping people make things happen with products that are smart, transparent, and easy to use
Happen Inc. (NASDAQ:HAPN) is a bank holding company that provides financial and lending services. The company offers deposit products, including savings accounts, checking accounts, and certificates of deposit. It also operates a lending marketplace that connects borrowers and financing options. The company was previously known as LendingClub Corporation and changed its name to Happen Inc. in June 2026. It was founded in 2006 and is headquartered in San Francisco, California.
3. Antero Resources Corp (NYSE:AR)
Forward P/E: 8.38
On July 7, Betty Jiang, an analyst from Barclays, maintained a Hold rating on Antero Resources Corp (NYSE:AR) and set a target price of $45. Despite the analyst’s Hold rating, the stock has seen positive momentum during the last few trading sessions. In contrast to Barclays, on June 30, Goldman Sachs analyst Neil Mehta kept a Buy rating on the stock while lowering the firm’s price target from $46 to $41. The firm’s downward price target still reflects 16% upside from current levels.
Antero Resources Corp.’s (NYSE:AR) second-quarter fiscal 2026 earnings report is scheduled to be announced on July 29. As per the company’s Q1 outlook, it revised its full-year 2026 production guidance to 4.1 Bcfe per day. Moreover, the company reduced its cash cost guidance by $0.10 per Mcfe. The company planned to invest about $1 billion in capital expenditure, with the option to increase spending to $1.2 billion, stated CEO and President Michael N. Kennedy. However, the additional $200 million is not guaranteed and remains under consideration. The oil and gas company expects benefits from the HG acquisition to increase over time, potentially generating $100 million in annual savings.
CFO Glen Warren, while emphasizing cost efficiencies, noted:
The integration of the HG acquisition has exceeded our expectations, delivering significant cost reductions and synergies.
Antero Resources Corp (NYSE:AR) is an independent oil and natural gas company that develops, produces, explores, and acquires natural gas, natural gas liquids (NGLs), and oil properties in the U.S.
2. Alaska Air Group, Inc. (NYSE:ALK)
Forward P/E: 7.58
Alaska Air Group, Inc. (NYSE:ALK) has been enjoying bullish analyst sentiment since the start of July. So far this month, 5 analysts have raised their price targets on the stock. In the latest update, Christopher Stathoulopoulos from Susquehanna raised the firm’s price target on ALK from $50 to $70 and reaffirmed a Buy rating. The price target revision was based on the firm’s expectations that airlines will benefit from lower fuel prices, strong travel demand, and stable ticket fares heading into the second-quarter earnings season.
In addition to Susquehanna, TD Cowen also raised its price target on Alaska Air Group, Inc. (NYSE:ALK) from $51 to $59 while maintaining its Buy rating on July 2. The firm updated its price targets across the airline sector as part of its second-quarter earnings preview.
TD Cowen said that it remains broadly positive on the airline sector, assuming the industry can maintain this year’s ticket price increases. However, the firm said that investors will likely look for confirmation that fare increases after Labor Day remain in place. They also want to see that travel demand stays strong before the airline stocks move higher.
Alaska Air Group, Inc. (NYSE:ALK) is an airline holding company operating through the Hawaiian Airlines, Alaska Airlines, and Regional segments. The company offers scheduled passenger and cargo flights using Boeing aircraft. It also provides air transportation services through Horizon Air and other third-party carriers.
1. UWM Holdings Corp (NYSE:UWMC)
Forward P/E: 4.72
UWM Holdings Corp (NYSE:UWMC) is one of the most undervalued growth stocks to buy for the next 10 years. On July 7, BTIG analyst Douglas Harter reiterated a Buy rating on the stock. He also assigned a target price of $4. On the same day, UWMC received another analyst’s attention. Terry Ma from Barclays maintained a Buy rating on the stock and set a target price of $4.
Earlier on June 2, Two Harbors Investment shareholders voted to approve the sale to CrossCountry Mortgage, meaning UWMC officially lost its bid to acquire TWO. Previously, on December 17 2025, UWM Holdings Corp (NYSE:UWMC) agreed to acquire TWO in a $1.3 billion all-stock deal. The company wanted to strengthen its position in the mortgage industry and expand its access to mortgage servicing rights by acquiring TWO. However, in March, CrossCountry offered an all-cash proposal. As a result, the real estate investment trust terminated its deal with UWMC, stating that CrossCountry’s proposal was superior. This setback leaves the company without the strategic and financial benefits it had expected to gain from the acquisition.
UWM Holdings Corporation (NYSE:UWMC) is a wholesale residential mortgage lender. The company is based in Pontiac, Michigan, and was founded in 1986.
READ NEXT: 10 Best AI Stocks to Watch in July and 12 Best Dow Stocks to Invest In Right Now.
Disclosure: None. Follow Insider Monkey on Google News.
Hedge Fund Resource Center